Compositions and methods of mRNA vaccines against novel coronavirus infection
Provided herein is a ribonucleic acid (RNA) encoding a spike (S) protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), or an immunogenic fragment thereof, the spike (S) protein or the immunogenic fragment thereof comprising at least one non-naturally occurring amino acid mutation....
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided herein is a ribonucleic acid (RNA) encoding a spike (S) protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), or an immunogenic fragment thereof, the spike (S) protein or the immunogenic fragment thereof comprising at least one non-naturally occurring amino acid mutation. In some embodiments, the S protein is derived from a delta variant. Related polynucleotides, vectors, cells, compositions, kits, methods of production, and methods of use are also provided.
本文提供了编码严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的刺突(S)蛋白或其免疫原性片段的核糖核酸(RNA),该刺突(S)蛋白或其免疫原性片段包含至少一个非天然存在的氨基酸突变。在一些实施方案中,该S蛋白来源于δ变体。另外提供了相关的多核苷酸、载体、细胞、组合物、试剂盒、生产方法和使用方法。 |
---|